Your browser doesn't support javascript.
loading
Toward the assembly and characterization of an encoded library hit confirmation platform: Bead-Assisted Ligand Isolation Mass Spectrometry (BALI-MS).
Ratnayake, Anokha S; Flanagan, Mark E; Foley, Timothy L; Hultgren, Scott L; Bellenger, Justin; Montgomery, Justin I; Lall, Manjinder S; Liu, Bo; Ryder, Tim; Kölmel, Dominik K; Shavnya, Andre; Feng, Xidong; Lefker, Bruce; Byrnes, Laura J; Sahasrabudhe, Parag V; Farley, Kathleen A; Chen, Shi; Wan, Jinqiao.
Affiliation
  • Ratnayake AS; Pfizer Worldwide Research and Development, Eastern Point Road, Groton, CT 06340, United States. Electronic address: anokha.ratnayake@pfizer.com.
  • Flanagan ME; Pfizer Worldwide Research and Development, Eastern Point Road, Groton, CT 06340, United States. Electronic address: mark.e.flanagan@pfizer.com.
  • Foley TL; Pfizer Worldwide Research and Development, Eastern Point Road, Groton, CT 06340, United States. Electronic address: Timothy.Foley@pfizer.com.
  • Hultgren SL; Pfizer Worldwide Research and Development, Eastern Point Road, Groton, CT 06340, United States. Electronic address: Scott.Hultgren@pfizer.com.
  • Bellenger J; Pfizer Worldwide Research and Development, Eastern Point Road, Groton, CT 06340, United States. Electronic address: Justin.Bellenger@pfizer.com.
  • Montgomery JI; Pfizer Worldwide Research and Development, Eastern Point Road, Groton, CT 06340, United States. Electronic address: Justin.Montgomery@pfizer.com.
  • Lall MS; Pfizer Worldwide Research and Development, Eastern Point Road, Groton, CT 06340, United States. Electronic address: Manjinder.Lall@pfizer.com.
  • Liu B; Pfizer Worldwide Research and Development, Eastern Point Road, Groton, CT 06340, United States. Electronic address: Bo.Liu2@pfizer.com.
  • Ryder T; Pfizer Worldwide Research and Development, Eastern Point Road, Groton, CT 06340, United States. Electronic address: tim.ryder@pfizer.com.
  • Kölmel DK; Pfizer Worldwide Research and Development, Eastern Point Road, Groton, CT 06340, United States. Electronic address: Dominik.Koelmel@pfizer.com.
  • Shavnya A; Pfizer Worldwide Research and Development, Eastern Point Road, Groton, CT 06340, United States. Electronic address: andre.shavnya@pfizer.com.
  • Feng X; Pfizer Worldwide Research and Development, Eastern Point Road, Groton, CT 06340, United States. Electronic address: Xidong.Feng@pfizer.com.
  • Lefker B; Lefker Biopharma Consulting LLC, Arlington, MA 02474 United States. Electronic address: bruce@lefkerbiopharmaconsulting.com.
  • Byrnes LJ; Pfizer Worldwide Research and Development, Eastern Point Road, Groton, CT 06340, United States. Electronic address: Laura.Byrnes@pfizer.com.
  • Sahasrabudhe PV; Pfizer Worldwide Research and Development, Eastern Point Road, Groton, CT 06340, United States. Electronic address: Parag.Sahasrabudhe@Pfizer.com.
  • Farley KA; Pfizer Worldwide Research and Development, Eastern Point Road, Groton, CT 06340, United States. Electronic address: kathleen.a.farley@pfizer.com.
  • Chen S; HitGen Inc., Shuangliu District, Chengdu, China. Electronic address: shi.chen@hitgen.com.
  • Wan J; HitGen Inc., Shuangliu District, Chengdu, China. Electronic address: jq.wan@hitgen.com.
Bioorg Med Chem ; 41: 116205, 2021 07 01.
Article in En | MEDLINE | ID: mdl-34000509
The ability to predict chemical structure from DNA sequence has to date been a necessary cornerstone of DNA-encoded library technology. DNA-encoded libraries (DELs) are typically screened by immobilized affinity selection and enriched library members are identified by counting the number of times an individual compound's sequence is observed in the resultant dataset. Those with high signal reads (DEL hits) are subsequently followed up through off-DNA synthesis of the predicted small molecule structures. However, hits followed-up in this manner often fail to translate to confirmed ligands. To address this low conversion rate of DEL hits to off-DNA ligands, we have developed an approach that eliminates the reliance on chemical structure prediction from DNA sequence. Here we describe our method of combining non-combinatorial resynthesis on-DNA following library procedures as a rapid means to assess the probable molecules attached to the DNA barcode. Furthermore, we apply our Bead-Assisted Ligand Isolation Mass Spectrometry (BALI-MS) technique to identify the true binders found within the mixtures of on-DNA synthesis products. Finally, we describe a Normalized Enrichment (NE) metric that allows for the quantitative assessment of affinity selection in these studies. We exemplify how this combined approach enables the identification of putative hit matter against a clinically relevant therapeutic target bisphosphoglycerate mutase, BPGM.
Subject(s)
Key words

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Mass Spectrometry / DNA / Gene Library / Drug Discovery Language: En Journal: Bioorg Med Chem Journal subject: BIOQUIMICA / QUIMICA Year: 2021 Document type: Article Country of publication:

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Mass Spectrometry / DNA / Gene Library / Drug Discovery Language: En Journal: Bioorg Med Chem Journal subject: BIOQUIMICA / QUIMICA Year: 2021 Document type: Article Country of publication: